Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SLXP > SEC Filings for SLXP > Form 8-K on 13-Jun-2013All Recent SEC Filings

Show all filings for SALIX PHARMACEUTICALS LTD | Request a Trial to NEW EDGAR Online Pro

Form 8-K for SALIX PHARMACEUTICALS LTD


13-Jun-2013

Other Events, Financial Statements and Exhibits


Item 8.01. Other Events.

On June 11, 2013, Salix Pharmaceuticals, Ltd. issued a joint press release with Progenics Pharmaceuticals, Inc. announcing that the FDA is seeking input from an Advisory Committee on Salix's Supplement New Drug Application for Relistor® (methylnaltrexone bromide) Subcutaneous Injection, for opioid-induced constipation in patients with chronic pain. A copy of this press release is attached as Exhibit 99.1.



Item 9.01. Financial Statements and Exhibits.

                (d)            Exhibits

                Exhibit No.    Description

                   99.1        Press release dated June 11, 2013.


  Add SLXP to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SLXP - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.